Correlation Between Standard Biotools and Neuronetics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Standard Biotools and Neuronetics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Standard Biotools and Neuronetics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Standard Biotools and Neuronetics, you can compare the effects of market volatilities on Standard Biotools and Neuronetics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Standard Biotools with a short position of Neuronetics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Standard Biotools and Neuronetics.

Diversification Opportunities for Standard Biotools and Neuronetics

0.11
  Correlation Coefficient

Average diversification

The 3 months correlation between Standard and Neuronetics is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding Standard Biotools and Neuronetics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neuronetics and Standard Biotools is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Standard Biotools are associated (or correlated) with Neuronetics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neuronetics has no effect on the direction of Standard Biotools i.e., Standard Biotools and Neuronetics go up and down completely randomly.

Pair Corralation between Standard Biotools and Neuronetics

Considering the 90-day investment horizon Standard Biotools is expected to under-perform the Neuronetics. But the stock apears to be less risky and, when comparing its historical volatility, Standard Biotools is 1.5 times less risky than Neuronetics. The stock trades about -0.01 of its potential returns per unit of risk. The Neuronetics is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  192.00  in Neuronetics on September 1, 2024 and sell it today you would lose (92.00) from holding Neuronetics or give up 47.92% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Standard Biotools  vs.  Neuronetics

 Performance 
       Timeline  
Standard Biotools 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Standard Biotools has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Standard Biotools is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Neuronetics 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Neuronetics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very weak forward indicators, Neuronetics displayed solid returns over the last few months and may actually be approaching a breakup point.

Standard Biotools and Neuronetics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Standard Biotools and Neuronetics

The main advantage of trading using opposite Standard Biotools and Neuronetics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Standard Biotools position performs unexpectedly, Neuronetics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neuronetics will offset losses from the drop in Neuronetics' long position.
The idea behind Standard Biotools and Neuronetics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities